Adverse Events of Moderna COVID-19 Vaccine In Japan(〜2022-3-20)

Vaccine name Spikevax
COVID-19 Vaccinations 51,618,647
Moderna global cases

※ Notice of Suspension of Use of Specific Lots of Moderna’s COVID-19 Vaccine in Japan. Takeda Pharmaceutical Company Limited announced

7 cases

ID Age  ▲ Symptoms Severity Outcome date Outcome Lot Number Causality Vaccinated Days after vaccination
28311 48
  • Vagal reflex(On the verge of fainting)
  • 2021-08-16
  • Recovered
3004956 Related 2021-08-16 0
28644 39
  • Vagal reflex(On the verge of fainting)
  • 2021-08-22
  • Recovered
3004956 Unevaluable 2021-08-22 0
28300 27
  • Rash, rash, erythema(rash)
  • 2021-08-20
  • Recovered
3004956 Related 2021-08-20 0
28642 37
  • Hypoglycemia(Hypoglycemia)
  • 2021-08-22
  • Recovered
3004956 Non_related 2021-08-22 0
28722 14
  • Itching(Itching)
  • erythema multiforme(erythema multiforme)
  • Rash, rash, erythema(rash)
  • Unknown
  • Unknown
  • Unknown
3004956 Unevaluable 2021-08-22 7
28643 37
  • stomach ache(upper abdominal pain)
  • cough(cough)
  • Nausea and vomiting(nausea)
  • 2021-08-22
  • 2021-08-22
  • 2021-08-22
  • Recovered
  • Recovered
  • Recovered
3004956 Non_related 2021-08-22 0
28826 31
  • cough(cough)
  • Chills(Chills)
  • Fever(Fever)
  • Relieved
  • Relieved
  • Relieved
3004956 Unevaluable 2021-08-23 0

7 cases